Research and Development

14 AI Solutions
Approved
R&D
Healthcare & Life Sciences
No logo

AI-designed CRISPR libraries. More effective guides, fewer false negatives, reduced bias, better affordability.

DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers our flagship DESKGEN CRISPR Library product range, which enables the work of our pharma, biotech and academic customers working in drug discovery, functional genomics and cell therapy.

Approved
Customer Support, Government Affairs, Marketing, R&D, Sales
All industries
No logo

Get more out of your data by applying natural language pocessing and semantic analysis techniques to etract valuable itelligence in real-time scenarios
Approved
R&D
Energy, Oil & Gas and Chemicals, Healthcare & Life Sciences, Manufacturing, Retail
No logo

Accelerate breakthroughs and surface discoveries.

SparkBeyond has built an automated research engine, capable of asking questions and discovering complex patterns in data. The technology is designed to leverage masses of data that exist on the web, intelligently augment your data and discover complex patterns. These patterns then become powerful tools for explaining, predicting and optimizing outcomes.

Approved
R&D
, All industries
No logo

Makes data science teams more productive through an open source platform for data prep, machine learning, and model deployment.
Approved
Business Insights, Customer Support, Marketing, R&D
All industries
No logo

An affordable, scalable and highly accurate set of tools that allow you to isolate the feedback that matters the most.

Understanding the changing needs of your customers is key to driving your business forward. It’s now easier than ever to find out the exact wants and needs of your customers.

Approved
Legal, R&D
All industries, Banking & Financial Services, Legal Services
No logo

Provides software solutions for automated text intelligence that are used by content owners who have large collections of documents in unstructured natural language.
Approved
Business Insights, R&D
All industries
No logo

Discovers outliers in vast amounts of time series data and turns them into valuable business insights.

Anodot is a real time analytics and automated anomaly detection system that discovers outliers in vast amounts of time series data and turns them into valuable business insights. Using patented machine learning algorithms, Anodot isolates issues and correlates them across multiple parameters in real time, eliminating business insight latency, and supporting rapid business decisions through its uncovered insights.With its scalable SaaS platform, Anodot provides typically siloed teams – BI, R&D and Devops – with a single, unified system for both business and IT metrics.

Approved
R&D
All industries
No logo

Understand what really drives your KPIs. Make your KPI optimization efforts painless, scalable and systematic.
Approved
R&D
Healthcare & Life Sciences
No logo

Predict the molecular effects of genetic variation, opening a new and exciting path to discovery for disease diagnostics and therapies.

Deep Genomics is building an integrated computational system, the DG Engine, which can learn, predict and interpret how genetic variation, whether natural or therapeutic, alters crucial cellular processes in the context of disease. Unlike other approaches, the DG Engine accounts for the complex, interdependent layers of biological processes that are involved in disease. The technology developed at Deep Genomics is based on machine learning, a powerful and practical form of artificial intelligence. We develop new machine learning methods that can find patterns in massive datasets and infer computer models of how cells read the genome and generate biomolecules. In this way, our unique technology provides a causal interpretation for genetic variation, not just the correlative information given by industry standard techniques. We can even generate networks of known and unknown variants based on how they affect the same cellular processes, something that was not previously possible. Any variant. Any disease. Our approach opens the door to a wide range of new techniques for classifying, prioritizing, interpreting and linking genetic variants and genetically derived therapies.

Jump to page:
1 2